Krzysztof Falenta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Krzysztof Falenta has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adam Dobek
Department of Radiology and Diagnostic Imaging, Barlicki University Hospital, Medical University of Łódź, 90-153 Łódź, Poland
5 shared publications - Ilona Kurnatowska
Department of Internal Diseases and Transplant Nephrology, Medical University of Lodz, 90-153 Lodz, Poland
5 shared publications - Ludomir Stefańczyk
Department of Radiology and Diagnostic Imaging, Barlicki University Hospital, Medical University of Łódź, 90-153 Łódź, Poland
5 shared publications - Piotr Białek
1st Department of Radiology and Diagnostic Imaging, Medical University of Lodz, Kopcinskiego 22 Street, 90-153 Lodz, Poland
5 shared publications - Michał Żuberek
Department of Internal Diseases and Transplant Nephrology, Medical University of Lodz, Lodz, Poland
4 shared publications Katarzyna Szychowska
Department of Internal Diseases and Transplant Nephrology, Medical University of Lodz, Lodz, Poland
3 shared publications
Latest Publications
- Open Access
- 13 January 2026
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 35 (3) , 481-491
Magnetic resonance-based quantification of post-renal biopsy perirenal hematomas volumes
Percutaneous renal biopsy (PRB) is the gold standard for diagnosing nephropathies but, despite being generally safe, it carries the risk of hemorrhagic complications, particularly perirenal hematomas (PHs). Ultrasound, although commonly used, tends to underestimate hematoma volumes, whereas computed tomography (CT) accurately measures volumes but poses radiation concerns and often requires contrast media. Magnetic resonance imaging (MRI), free of these risks, offers high tissue resolution but remains underutilized for PH evaluation post-PRB. To evaluate the utility of MRI-based segmentation techniques for accurately quantifying PH volumes after PRB, as a complementary imaging modality to ultrasound and CT. We retrospectively analyzed MRI data from 85 patients who underwent PRB between July 2020 and May 2024. MRI-derived PH volumes were measured using manual segmentation. Clinical data were extracted from patient records, and the results were compared with data from a previous CT-based study. Perirenal hematoma was detected in 63 patients (74.1%) with a median volume of 26.2 mL (interquartile range (IQR): 7.2-59.3 mL), slightly smaller than CT-derived volumes (median: 38 mL, IQR: 18-85 mL). Using Spearman's rank correlation coefficient (rs), we found that serum creatinine (Cr; rs = 0.299, p = 0.039) and systolic blood pressure (SBP; rs = 0.333, p = 0.017) correlated positively with PH volume, while hemoglobin levels showed a negative correlation (rs = -0.322, p = 0.021). Hemodialysis was associated with larger PHs (odds ratio (OR) = 4.59, 95% confidence interval (95% CI): 1.20-17.58, p = 0.026); however, this finding is based on a model with modest predictive performance and requires further validation. Although its routine use may be limited, MRI could serve as a complementary tool for the detailed evaluation of PHs, offering a radiation-free and contrast media-free alternative to CT in clinical scenarios where immediate decision-making is not critical.
- 13 January 2026
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 35 (3) , 481-491
Open AccessMagnetic resonance-based quantification of post-renal biopsy perirenal hematomas volumes
Percutaneous renal biopsy (PRB) is the gold standard for diagnosing nephropathies but, despite being generally safe, it carries the risk of hemorrhagic complications, particularly perirenal hematomas (PHs). Ultrasound, although commonly used, tends to underestimate hematoma volumes, whereas computed tomography (CT) accurately measures volumes but poses radiation concerns and often requires contrast media. Magnetic resonance imaging (MRI), free of these risks, offers high tissue resolution but remains underutilized for PH evaluation post-PRB. To evaluate the utility of MRI-based segmentation techniques for accurately quantifying PH volumes after PRB, as a complementary imaging modality to ultrasound and CT. We retrospectively analyzed MRI data from 85 patients who underwent PRB between July 2020 and May 2024. MRI-derived PH volumes were measured using manual segmentation. Clinical data were extracted from patient records, and the results were compared with data from a previous CT-based study. Perirenal hematoma was detected in 63 patients (74.1%) with a median volume of 26.2 mL (interquartile range (IQR): 7.2-59.3 mL), slightly smaller than CT-derived volumes (median: 38 mL, IQR: 18-85 mL). Using Spearman's rank correlation coefficient (rs), we found that serum creatinine (Cr; rs = 0.299, p = 0.039) and systolic blood pressure (SBP; rs = 0.333, p = 0.017) correlated positively with PH volume, while hemoglobin levels showed a negative correlation (rs = -0.322, p = 0.021). Hemodialysis was associated with larger PHs (odds ratio (OR) = 4.59, 95% confidence interval (95% CI): 1.20-17.58, p = 0.026); however, this finding is based on a model with modest predictive performance and requires further validation. Although its routine use may be limited, MRI could serve as a complementary tool for the detailed evaluation of PHs, offering a radiation-free and contrast media-free alternative to CT in clinical scenarios where immediate decision-making is not critical.
- Open Access
- 29 November 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 2943
Reporting of Perirenal Hematoma Size After Ultrasound-Guided Renal Biopsy in Adults: A Scoping Review
Introduction: Percutaneous renal biopsy (PRB) is the gold standard for diagnosing nephropathies, but it carries a risk of bleeding complications, mainly perinephric hematomas (PHs). While PH incidence is often reported, the significance of PH size remains insufficiently explored. This scoping review systematically mapped the evidence on PH size after ultrasound-guided PRB in adults, focusing on imaging modalities, measurement methods, the definition of ‘large’ PH, factors influencing PH size, and its clinical implications. Materials and Methods: Following the Joanna Briggs Institute methodology, we searched PubMed/MEDLINE, Embase, Cochrane CENTRAL, and Scopus through 27 August 2025. Eligible studies included at least 50 adult subjects undergoing ultrasound-guided PRB with quantitative, imaging-based assessment of PH size. Results: Fifty-one studies met the inclusion criteria. Almost all relied on ultrasound, with only one using computed tomography. PH size was measured using heterogeneous methods, most often one-dimensional diameters, less frequently surface area or volumetry, with no standardization. Reported PH frequencies varied substantially across studies (1.1–85%), likely reflecting differences in imaging protocols, timing, and reporting thresholds. Several studies proposed PH size thresholds (e.g., diameter ≥ 2–3 cm, volume ≥ 40–85 mL) linked to adverse outcomes such as transfusion or hemodynamic instability. Factors associated with larger PHs included needle gauge, number of passes, impaired kidney function, coagulopathy, and certain histopathologies. Conclusions: PH size has prognostic value beyond incidence alone. Standardized measurement and reporting are needed to clarify its clinical relevance after PRB.
- 29 November 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 2943
Open AccessReporting of Perirenal Hematoma Size After Ultrasound-Guided Renal Biopsy in Adults: A Scoping Review
Introduction: Percutaneous renal biopsy (PRB) is the gold standard for diagnosing nephropathies, but it carries a risk of bleeding complications, mainly perinephric hematomas (PHs). While PH incidence is often reported, the significance of PH size remains insufficiently explored. This scoping review systematically mapped the evidence on PH size after ultrasound-guided PRB in adults, focusing on imaging modalities, measurement methods, the definition of ‘large’ PH, factors influencing PH size, and its clinical implications. Materials and Methods: Following the Joanna Briggs Institute methodology, we searched PubMed/MEDLINE, Embase, Cochrane CENTRAL, and Scopus through 27 August 2025. Eligible studies included at least 50 adult subjects undergoing ultrasound-guided PRB with quantitative, imaging-based assessment of PH size. Results: Fifty-one studies met the inclusion criteria. Almost all relied on ultrasound, with only one using computed tomography. PH size was measured using heterogeneous methods, most often one-dimensional diameters, less frequently surface area or volumetry, with no standardization. Reported PH frequencies varied substantially across studies (1.1–85%), likely reflecting differences in imaging protocols, timing, and reporting thresholds. Several studies proposed PH size thresholds (e.g., diameter ≥ 2–3 cm, volume ≥ 40–85 mL) linked to adverse outcomes such as transfusion or hemodynamic instability. Factors associated with larger PHs included needle gauge, number of passes, impaired kidney function, coagulopathy, and certain histopathologies. Conclusions: PH size has prognostic value beyond incidence alone. Standardized measurement and reporting are needed to clarify its clinical relevance after PRB.
- Open Access
- 22 November 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 58 (6) , 2283-2296
Volumetric MRI assessment of perirenal hematoma following biopsy of native and transplanted kidneys
Background Percutaneous renal biopsy (PRB) is the gold standard for diagnosing nephropathies but carries a risk of complications, most commonly perirenal hematoma (PH). Although usually minor, PH volume is rarely quantified, and ultrasound—the standard modality—has limited accuracy. Magnetic resonance imaging (MRI) enables precise volumetric assessment and may improve understanding of PH pathophysiology. Materials and methods This retrospective study included 138 patients (104 with native kidneys, 34 with grafts) who underwent kidney MRI 36–48 h after PRB. PHs were manually segmented on T1-weighted Dixon water-only images. Predictors of large PHs (upper tertile of volume) were identified using logistic regression, and model stability was evaluated with leave-one-out cross-validation (LOOCV). As an exploratory analysis, apparent diffusion coefficient (ADC) values were obtained from diffusion-weighted imaging (DWI) maps to assess correlations between renal diffusivity and PH volume. Results PH was detected in 89.9% of cases. Median PH volume was significantly lower in grafts than in native kidneys (9.3 mL vs. 20.95 mL, p = 0.030). Graft status was an independent negative predictor of large PH, while kidney volume (KV), diastolic blood pressure (DBP), and proteinuria were independent positive predictors. The final model showed moderate discriminative performance (AUC = 0.708). Lower ADC values correlated moderately and negatively with PH volume (rho = –0.41, p = 0.009). Conclusion MRI volumetry enables precise assessment of PH after PRB. Larger KV, higher DBP and proteinuria predicted greater PH volume, while graft status was protective. Lower renal parenchymal ADC values may reflect microstructural alterations predisposing to increased PH volume but warrants further evaluation in future studies.
- 22 November 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 58 (6) , 2283-2296
Open AccessVolumetric MRI assessment of perirenal hematoma following biopsy of native and transplanted kidneys
Background Percutaneous renal biopsy (PRB) is the gold standard for diagnosing nephropathies but carries a risk of complications, most commonly perirenal hematoma (PH). Although usually minor, PH volume is rarely quantified, and ultrasound—the standard modality—has limited accuracy. Magnetic resonance imaging (MRI) enables precise volumetric assessment and may improve understanding of PH pathophysiology. Materials and methods This retrospective study included 138 patients (104 with native kidneys, 34 with grafts) who underwent kidney MRI 36–48 h after PRB. PHs were manually segmented on T1-weighted Dixon water-only images. Predictors of large PHs (upper tertile of volume) were identified using logistic regression, and model stability was evaluated with leave-one-out cross-validation (LOOCV). As an exploratory analysis, apparent diffusion coefficient (ADC) values were obtained from diffusion-weighted imaging (DWI) maps to assess correlations between renal diffusivity and PH volume. Results PH was detected in 89.9% of cases. Median PH volume was significantly lower in grafts than in native kidneys (9.3 mL vs. 20.95 mL, p = 0.030). Graft status was an independent negative predictor of large PH, while kidney volume (KV), diastolic blood pressure (DBP), and proteinuria were independent positive predictors. The final model showed moderate discriminative performance (AUC = 0.708). Lower ADC values correlated moderately and negatively with PH volume (rho = –0.41, p = 0.009). Conclusion MRI volumetry enables precise assessment of PH after PRB. Larger KV, higher DBP and proteinuria predicted greater PH volume, while graft status was protective. Lower renal parenchymal ADC values may reflect microstructural alterations predisposing to increased PH volume but warrants further evaluation in future studies.
- Open Access
- 20 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5888
Opportunistic Detection of Chronic Kidney Disease Using CT-Based Measurements of Kidney Volume and Perirenal Fat
Background/Objectives: Chronic kidney disease (CKD) is a prevalent condition with many cases remaining undiagnosed, although early detection is essential. Adipose tissue distribution—particularly perirenal fat thickness (PrFT)—has recently been linked to renal pathophysiology. This study assessed the association between CT-derived parameters of fat distribution and kidney morphology with CKD. Materials and Methods: This retrospective study included 237 patients (117 subjects, 120 controls) who underwent abdominal CT and had serum creatinine data. The dataset was randomly split (70% training, 30% test) to develop and evaluate a logistic regression model. CKD was defined as estimated Glomerular Filtration Rate (eGFR) < 60 mL/min/1.73 m2. PrFT was measured as the distance from the posterior renal capsule to the posterior abdominal wall; renal hilum fat was segmented using a −195 to −45 HU range. Additional parameters (measured using automated segmentation tools) included kidney volume (KV), visceral/subcutaneous fat areas, skeletal muscle area and attenuation, and liver attenuation. Bilateral measurements were averaged. Results: KV (OR = 0.249, 95% CI: 0.146–0.422, p < 0.001) and PrFT (2nd tercile: OR = 7.720, 95% CI: 2.860–20.839; 3rd tercile: OR = 16.892, 95% CI: 5.727–49.822; both p < 0.001) were identified as independent predictors of CKD. These variables were used to construct a simplified model, which demonstrated moderate clinical applicability (AUC = 0.894) when evaluated on the test subset. Conclusions: KV and PrFT emerged as independent predictors of CKD, forming the basis of a simplified model with potential for opportunistic clinical application. This approach may facilitate earlier detection of CKD in patients undergoing CT imaging for unrelated clinical reasons. These imaging parameters are not intended to replace serum creatinine or eGFR but may serve as complementary predictors in specific clinical contexts.
- 20 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5888
Open AccessOpportunistic Detection of Chronic Kidney Disease Using CT-Based Measurements of Kidney Volume and Perirenal Fat
Background/Objectives: Chronic kidney disease (CKD) is a prevalent condition with many cases remaining undiagnosed, although early detection is essential. Adipose tissue distribution—particularly perirenal fat thickness (PrFT)—has recently been linked to renal pathophysiology. This study assessed the association between CT-derived parameters of fat distribution and kidney morphology with CKD. Materials and Methods: This retrospective study included 237 patients (117 subjects, 120 controls) who underwent abdominal CT and had serum creatinine data. The dataset was randomly split (70% training, 30% test) to develop and evaluate a logistic regression model. CKD was defined as estimated Glomerular Filtration Rate (eGFR) < 60 mL/min/1.73 m2. PrFT was measured as the distance from the posterior renal capsule to the posterior abdominal wall; renal hilum fat was segmented using a −195 to −45 HU range. Additional parameters (measured using automated segmentation tools) included kidney volume (KV), visceral/subcutaneous fat areas, skeletal muscle area and attenuation, and liver attenuation. Bilateral measurements were averaged. Results: KV (OR = 0.249, 95% CI: 0.146–0.422, p < 0.001) and PrFT (2nd tercile: OR = 7.720, 95% CI: 2.860–20.839; 3rd tercile: OR = 16.892, 95% CI: 5.727–49.822; both p < 0.001) were identified as independent predictors of CKD. These variables were used to construct a simplified model, which demonstrated moderate clinical applicability (AUC = 0.894) when evaluated on the test subset. Conclusions: KV and PrFT emerged as independent predictors of CKD, forming the basis of a simplified model with potential for opportunistic clinical application. This approach may facilitate earlier detection of CKD in patients undergoing CT imaging for unrelated clinical reasons. These imaging parameters are not intended to replace serum creatinine or eGFR but may serve as complementary predictors in specific clinical contexts.